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Elevations in serum levels of pancreatic enzymes are
usually in the range of 14–80% in intensive care unit
(ICU) patients who have no prior pancreatic pathol-
ogy.1,2 Although most of these patients do not develop
clinical pancreatitis, pancreatic damage associated with
elevated pancreatic enzymes is present. It is difficult to
assess the clinical symptoms and signs of acute pancre-
atitis in ICU patients, especially in comatose, sedated,
or mechanically ventilated patients. Serum amylase and
lipase exceeding 3 times the upper normal limit are
considered part of the criteria to diagnose acute pan-
creatitis.3 However, neither amylase nor lipase is specific
for acute pancreatitis, and elevation of amylase and
lipase does not correlate with the severity of pancre-
atitis. Imaging studies including abdominal ultrasonog-
raphy and computed tomography (CT) are important
tools to assess the etiology of elevated pancreatic
enzymes. Imaging work-up for pancreatic damage is
indicated for ICU patients with serum amylase or lipase
levels >3 times the upper normal limit.
What is the incidence of pancreatitis in ICU patients
with increased serum amylase and lipase? In a recent
issue of the Journal of the Chinese Medical Association,
Lee et al4 reported their retrospective study that eval-
uated the clinical implication of increased serum levels
of amylase and lipase in 89 neurosurgery ICU patients
with abdominal symptoms and signs. Nearly half of these
patients (48.3%) had elevated serum amylase and lipase.
Nine out of 34 (26.5%) patients who were highly sus-
pected to have acute pancreatitis (according to symp-
toms, signs, serum amylase and lipase levels >3 and >5
times, respectively, the upper normal limit), with peri-
toneal signs or fever of unknown origin, had imaging
findings of pancreatitis on ultrasonography and/or
CT. Only 1 of 9 patients had moderate pancreatitis; the
others had mild pancreatitis. The exact causes of pan-
creatitis were not shown in the study. Manjuck et al5
found that imaging evidence of pancreatitis was present
in 22% (11/50) of ICU patients with elevated lipase
levels (above the upper normal limit). Denz et al2
recently reported that 7 out of 20 (35%) ICU patients
with serum lipase levels >3 times the normal value had
morphological alterations of the pancreas seen on
contrast-enhanced CT.
Is increased serum pancreatic enzymes in ICU
patients associated with higher mortality or longer
ICU stay? Liu et al6 and Manjuck et al5 reported that
ICU patients with elevated amylase and lipase levels did
not have higher mortality, but had longer hospital or
ICU stays compared to patients with normal amylase
and lipase levels. On the contrary, Lee et al4 found
that the mortality rate in patients with abnormal serum
amylase and lipase levels was significantly higher than
that in patients with normal amylase and lipase levels
(39.5% vs. 17.4%, p = 0.033), and elevation of pancre-
atic enzyme was not associated with longer ICU stay.
Chronic renal failure is commonly related to ele-
vated serum amylase and lipase levels. The percentages
of serum amylase and lipase greater than the upper
normal limits in patients with chronic renal failure were
35.7% and 26.2%, respectively.7 In their study, Lee et al4
confirmed that renal failure may cause elevation of
serum amylase and lipase. The percentage of renal failure
(serum creatinine>1.5 mg/dL) in patients with abnor-
mal amylase and lipase levels was significantly higher
than that in patients with normal amylase and lipase
levels (27.9% vs. 8.7%, p = 0.026).
The pathophysiology of pancreatic damage in gen-
eral ICU or neurosurgery ICU patients is diverse.
Several factors are proposed, including splanchnic
hypoperfusion, bacterial translocation, elevated triglyc-
eride levels, biliary sludge, head injury, acute stroke and
drug adverse effects. Pancreatic damage associated with
major surgery or shock has been well documented. The
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pancreas is highly susceptible to hypoperfusion and
reperfusion injury. Nys et al8 reported a biphasic ele-
vation of pancreatic enzymes in patients undergoing
vascular surgery. The first peak occurred postopera-
tively and was related to ischemia, while the second
peak developed 4–8 days after surgery and may be
driven by inflammation.
Vitale et al9 showed that 23 out of 60 (38%) patients
with severe head injury had increased total serum amy-
lase levels. The source of hyperamylasemia was pancre-
atic isoamylase in 14, non-pancreatic isoamylase in 1,
and mixed in 8 patients. However, no evidence of acute
pancreatitis was found in these patients. In the report by
Lee et al,4 patients with head injury or intracranial hem-
orrhage were found to have higher serum amylase and
lipase levels compared with other neurosurgery ICU
patients (p =0.04). Liu et al10 reported a rare case of
acute pancreatitis that developed 10 hours after tem-
poral lobectomy and hippocampectomy in a 23-year-old
male patient with intractable seizure. Whether or not
brain surgery affects the serum levels of pancreatic
enzymes was not shown by Lee et al’s study.4 They did
not compare pancreatic enzyme levels before and after
the surgical procedures.
The mechanism of the association between brain
injury and acute pancreatitis or hyperamylasemia is
unclear. Patients with acute traumatic brain injury are
known to be hypermetabolic and have increased nutri-
tional requirements.11 Relative malnutrition and refeed-
ing after malnutrition are known risk factors for the
development of pancreatitis. In patients with head
injury or acute stroke, the pancreas could also be af-
fected by a failure of central regulation such as increased
vagal activity, inappropriate cholecystokinin stimula-
tion, or altered sympathetic tone.12
Propofol sedation was reported to cause higher inci-
dence of hyperamylasemia in ICU patients (propofol
53% vs. non-propofol 14%, p =0.0021).13 The causal
mechanism of propofol-induced pancreatitis is unclear.
Hypertriglyceridemia is proposed as a putative mech-
anism. However, there was no significant elevation of
pancreatic enzymes after propofol use in neurosurgery
ICU patients in Lee et al’s study.4
The incidence of exocrine pancreatic insufficiency in
severely traumatized patients was reported to be 55.6%
by measuring fecal elastase-1.14 Pancreatic exocrine dys-
function is related to the severity of illness in sepsis and
ICU patients.15 Accordingly, pancreatic enzyme supple-
mentation is necessary for these patients when enteral
nutrition is tolerated.
In conclusion, elevation in serum amylase and
lipase levels is common in ICU/neurosurgery ICU
patients. Acute pancreatitis is uncommon in these pa-
tients, and most pancreatitis observed is mild. Pancre-
atic enzyme supplementation may be necessary for
ICU patients in whom feeding is tolerated. Whether
or not elevated pancreatic enzymes is associated with
higher mortality or longer ICU stay needs to be clari-
fied with a large-scale study.
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